✦ LIBER ✦
Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases
✍ Scribed by M. Klinger; S. Eipeldauer; S. Hacker; B. Herberger; D. Tamandl; M. Dorfmeister; C. Koelblinger; B. Gruenberger; T. Gruenberger
- Book ID
- 116443480
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 161 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0748-7983
No coin nor oath required. For personal study only.